2019 investment update – who are the gen(e)ius investors placing bets on gene therapy companies?
This year’s numerous gene therapy acquisition and licensing deals, market approvals and other regulatory milestones indicate a great future for this innovative field. The field’s shown major advances in 2019 and has a forecasted growth of 24% CAGR over 2018-2024. There are a number of risk-thirsty investors ready to encourage gene therapy innovation. Curiosity drew us in, and we’ve dug into the challenges as well as the who’s who of the investors in the gene therapy space.
December 17, 2019
Our success depends on how well our clients perform. We are here to equip them with the right tools and empower them with the right insight, so they confidently can strike deals, partnerships and attract investments.
We understand the business issues facing smaller biotech companies and share a passion with our clients to drive the future of medicine.
We support leaders with actionable recommendations and insights with a fervor and razor-sharp focus. Our approach is doing so by creating tailored solutions to challenging business issues and crafting strategies to achieve business goals and brand visibility. Whether it is business development, asset valuation or communication, we are a reliable partner that always walk that extra mile.